These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1953964)

  • 1. Quantitative EEG during a double-blind trial of THA and lecithin in patients with Alzheimer's disease.
    Perryman KM; Fitten LJ
    J Geriatr Psychiatry Neurol; 1991; 4(3):127-33. PubMed ID: 1953964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG.
    Minthon L; Gustafson L; Dalfelt G; Hagberg B; Nilsson K; Risberg J; Rosén I; Seiving B; Wendt PE
    Dementia; 1993; 4(1):32-42. PubMed ID: 8358504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.
    Wilcock GK; Surmon DJ; Scott M; Boyle M; Mulligan K; Neubauer KA; O'Neill D; Royston VH
    Age Ageing; 1993 Sep; 22(5):316-24. PubMed ID: 8237620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
    Chatellier G; Lacomblez L
    BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed matching-to-sample performance during a double-blind trial of tacrine (THA) and lecithin in patients with Alzheimer's disease.
    Perryman KM; Fitten LJ
    Life Sci; 1993; 53(6):479-86. PubMed ID: 8341134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
    Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
    N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term tetrahydroaminoacridine treatment and quantitative EEG in Alzheimer's disease.
    Kogan EA; Verchovsky RG; Neufeld MY; Klimovitsky SSh; Treves TA; Korczyn AD
    J Neural Transm Suppl; 2007; (72):203-6. PubMed ID: 17982896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study.
    Fitten LJ; Perryman KM; Gross PL; Fine H; Cummins J; Marshall C
    Am J Psychiatry; 1990 Feb; 147(2):239-42. PubMed ID: 2405720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
    Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
    Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
    Almkvist O; Jelic V; Amberla K; Hellström-Lindahl E; Meurling L; Nordberg A
    Dement Geriatr Cogn Disord; 2001; 12(1):22-32. PubMed ID: 11125238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID.
    Saletu B; Anderer P; Fischhof PK; Lorenz H; Barousch R; Böhmer F
    Biol Psychiatry; 1992 Oct; 32(8):668-81. PubMed ID: 1457622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPECT brain imaging in Alzheimer's disease during treatment with oral tetrahydroaminoacridine and lecithin.
    Cohen MB; Fitten LJ; Lake RR; Perryman KM; Graham LS; Sevrin R
    Clin Nucl Med; 1992 Apr; 17(4):312-5. PubMed ID: 1572123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physostigmine and tetrahydroaminoacridine treatment of Alzheimer's disease.
    Gustafson L
    Acta Neurol Scand Suppl; 1993; 149(Rand):39-41. PubMed ID: 8128836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EEG regional changes during long-term treatment with tetrahydroaminoacridine (THA) in Alzheimer's disease.
    Shigeta M; Persson A; Viitanen M; Winblad B; Nordberg A
    Acta Neurol Scand Suppl; 1993; 149():58-61. PubMed ID: 8128842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topography of the quantitative electroencephalogram in dementia of the Alzheimer type: relation to severity of dementia.
    Dierks T; Perisic I; Frölich L; Ihl R; Maurer K
    Psychiatry Res; 1991 Nov; 40(3):181-94. PubMed ID: 1780391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaco-EEG test dose response predicts cholinesterase inhibitor treatment outcome in Alzheimer's disease.
    Knott V; Mohr E; Mahoney C; Ilivitsky V
    Methods Find Exp Clin Pharmacol; 2000 Mar; 22(2):115-22. PubMed ID: 10849895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in absolute power values of EEG spectra in the follow-up of Alzheimer's disease.
    Soininen H; Partanen J; Pääkkönen A; Koivisto E; Riekkinen PJ
    Acta Neurol Scand; 1991 Feb; 83(2):133-6. PubMed ID: 2017898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THA does not affect sleep or EEG spectral power in Alzheimer's disease.
    Petit D; Montplaisir J; Lorrain D; Gauthier S
    Biol Psychiatry; 1993 May; 33(10):753-4. PubMed ID: 8353172
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and assessment of dementia using functional brain imaging.
    Leuchter AF; Walter DO
    Int Psychogeriatr; 1989; 1(1):63-72. PubMed ID: 2490905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
    Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
    Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.